Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$15.27
+0.2%		$14.82
$9.39
▼
$16.29
$629.90M0.33282,893 shs341,959 shs
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$13.93
+0.1%		$15.08
$7.14
▼
$17.40
$559.29M1.2582,889 shs68,033 shs
FOCL
FocalTherics
$4.10
-1.4%		$5.12
$1.75
▼
$6.40
$156.12M-0.07139,622 shs66,303 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$22.06
+2.3%		$22.01
$14.42
▼
$26.74
$562.93M0.99222,382 shs239,520 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
+0.20%+0.46%-3.05%+26.20%+39.58%
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
+0.14%-1.55%-16.08%-4.78%+74.89%
FOCL
FocalTherics
-1.44%-1.20%-13.68%-13.14%+409,999,900.00%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+2.32%-1.56%-11.26%+23.79%+14.36%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$15.27
+0.2%		$14.82
$9.39
▼
$16.29
$629.90M0.33282,893 shs341,959 shs
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$13.93
+0.1%		$15.08
$7.14
▼
$17.40
$559.29M1.2582,889 shs68,033 shs
FOCL
FocalTherics
$4.10
-1.4%		$5.12
$1.75
▼
$6.40
$156.12M-0.07139,622 shs66,303 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$22.06
+2.3%		$22.01
$14.42
▼
$26.74
$562.93M0.99222,382 shs239,520 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
+0.20%+0.46%-3.05%+26.20%+39.58%
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
+0.14%-1.55%-16.08%-4.78%+74.89%
FOCL
FocalTherics
-1.44%-1.20%-13.68%-13.14%+409,999,900.00%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+2.32%-1.56%-11.26%+23.79%+14.36%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
2.40
Hold$19.5027.70% Upside
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
2.71
Moderate Buy$18.2030.65% Upside
FOCL
FocalTherics
2.40
Hold$7.7589.02% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.73
Moderate Buy$26.4419.88% Upside

Current Analyst Ratings Breakdown

Latest FOCL, ANGO, KIDS, and BWAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/10/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$20.00
9/8/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$19.00
8/31/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $19.00
8/25/2026
FOCL
FocalTherics
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$10.00
8/20/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$24.00 ➝ $29.00
8/19/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B-) ➝ Hold (C+)
8/17/2026
FOCL
FocalTherics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/14/2026
FOCL
FocalTherics
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$4.00
8/13/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
LADENBURG THALM/SH SH logo
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$18.00 ➝ $18.80
8/12/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$18.00 ➝ $20.00
8/11/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$320.17M1.97$0.31 per share48.71$4.13 per share3.70
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$52.22M10.73$0.23 per share59.41$1.87 per share7.45
FOCL
FocalTherics
$79.31M1.94N/AN/A$0.52 per share7.88
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$236.35M2.44$0.17 per share129.66$13.82 per share1.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$36.74M-$0.87N/AN/AN/A-11.48%-5.73%-3.77%10/1/2026 (Estimated)
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$7.57M$0.4431.6624.44N/A15.65%12.74%8.17%11/10/2026 (Estimated)
FOCL
FocalTherics
-$29.25M-$1.03N/AN/AN/A-56.26%-248.00%-44.69%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-15.72%-8.10%-5.54%10/27/2026 (Estimated)

Latest FOCL, ANGO, KIDS, and BWAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/1/2026Q1 2027
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.1125N/AN/AN/A$80.51 millionN/A
8/14/2026Q2 2026
FOCL
FocalTherics
-$0.20-$0.39-$0.19-$0.39N/A$13.20 million
8/12/2026Q2 2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$0.10$0.14+$0.04$0.07$16.54 million$17.11 million
8/4/2026Q2 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.3022-$0.26+$0.0422-$0.30$68.21 million$70.51 million
7/14/2026Q4 2026
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.11-$0.07+$0.04-$0.27$80.24 million$86.61 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/AN/AN/AN/AN/A
FOCL
FocalTherics
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
2.19
1.49
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/A
3.59
3.27
FOCL
FocalTherics
1.79
1.60
1.38
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.28
4.78
2.17

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
30.11%
FOCL
FocalTherics
62.74%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%

Insider Ownership

CompanyInsider Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
6.00%
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
19.00%
FOCL
FocalTherics
10.10%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
76041.33 million38.85 millionOptionable
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
12040.21 million32.57 millionNot Optionable
FOCL
FocalTherics
23037.53 million33.74 millionN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20026.11 million17.62 millionOptionable

Recent News About These Companies

OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 302,369 Shares
September 12 at 6:22 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-kids-insider-buying-and-selling-2026-09-12/
How Orthopediatrics Corp. (KIDS) Affects Rotational Strategy Timing
September 11 at 10:43 PM  |  news.stocktradersdaily.comN
Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 302,369 Shares of Stock
September 11 at 9:06 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-orthopediatrics-nasdaq-kids-major-shareholder-sells-302369-shares-of-stock-2026-09-11/
OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 302,369 Shares
September 11 at 9:06 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-orthopediatrics-nasdaq-kids-major-shareholder-sells-302369-shares-2026-09-11/
OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher
September 11 at 7:36 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/orthopediatrics-kids-crosses-70m-guidance-051006390.html
OrthoPediatrics (NASDAQ:KIDS) Director David Pelizzon Sells 302,369 Shares
September 11 at 6:22 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-kids-insider-buying-and-selling-2026-09-11/
Bank of New York Mellon Corp Buys New Stake in OrthoPediatrics Corp. $KIDS
September 11 at 3:20 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-buys-new-stake-in-orthopediatrics-corp-kids-2026-09-11/
OrthoPediatrics (NASDAQ:KIDS) Director David Pelizzon Sells 302,369 Shares of Stock
September 10 at 5:06 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-orthopediatrics-nasdaq-kids-director-david-pelizzon-sells-302369-shares-of-stock-2026-09-10/
OrthoPediatrics (NASDAQ:KIDS) Sees Strong Trading Volume - What's Next?
September 10 at 12:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-orthopediatrics-nasdaq-kids-sees-strong-trading-volume-whats-next-2026-09-10/
Wellington Management Group LLP Has $15.20 Million Position in OrthoPediatrics Corp. $KIDS
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wellington-management-group-llp-has-1520-million-position-in-orthopediatrics-corp-kids-2026-09-08/
Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $525,375.00 in Stock
September 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31009102
OrthoPediatrics (NASDAQ:KIDS) Director Sells $525,375.00 in Stock
September 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31009083
OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $525,375.00 in Stock
September 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31009042
David Pelizzon Sells 22,500 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock
September 5, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-kids-insider-buying-and-selling-2026-09-05/
OrthoPediatrics (NASDAQ:KIDS) Director David Pelizzon Sells 22,500 Shares of Stock
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-orthopediatrics-nasdaq-kids-director-david-pelizzon-sells-22500-shares-of-stock-2026-09-04/
OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 22,500 Shares of Stock
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-orthopediatrics-nasdaq-kids-major-shareholder-sells-22500-shares-of-stock-2026-09-04/
OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Jennifer Pritzker Sells 22,500 Shares
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-orthopediatrics-nasdaq-kids-major-shareholder-jennifer-pritzker-sells-22500-shares-2026-09-04/
OrthoPediatrics (NASDAQ:KIDS) Director Sells $7,527,168.00 in Stock
September 4, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31003354
Jennifer Pritzker Sells 326,700 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock
September 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31001485
BlackRock Inc. Takes Position in OrthoPediatrics Corp. $KIDS
September 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-blackrock-inc-takes-position-in-orthopediatrics-corp-kids-2026-09-03/
OrthoPediatrics (NASDAQ:KIDS) Director David Pelizzon Sells 10,131 Shares of Stock
September 2, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-kids-insider-buying-and-selling-2026-09-02/

New MarketBeat Followers Over Time

Media Sentiment Over Time

AngioDynamics stock logo

AngioDynamics NASDAQ:ANGO

$15.27 +0.03 (+0.20%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$15.26 0.00 (-0.03%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Brainsway stock logo

Brainsway NASDAQ:BWAY

$13.93 +0.02 (+0.14%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$13.92 -0.01 (-0.07%)
As of 09/11/2026 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

FocalTherics NASDAQ:FOCL

$4.10 -0.06 (-1.44%)
As of 09/11/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$22.06 +0.50 (+2.32%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$22.05 -0.01 (-0.05%)
As of 09/11/2026 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas